C2 PHARMA is a European pharmaceutical group that specializes in the manufacturing and distribution of active pharmaceutical ingredients (APIs) and complex chemical compounds derived from both natural and synthetic origins. Established in 2014, C2 PHARMA has positioned itself as the global leader in ophthalmic APIs, providing high-quality products to a diverse clientele that includes over 200 pharmaceutical companies across the United States, Western and Eastern Europe, South America, Asia, the Middle East, and Africa. The company's extensive portfolio features a wide range of APIs, contributing to advancements in various therapeutic areas.

Services include:
- Manufacturing
- APIs (Active Pharmaceutical Ingredients)
- Ophthalmics
- Process Development
- Process R&D
- Contract Development and Manufacturing (CDMO)
- Drug Delivery Devices & Systems
- Customised GDP cold-chain warehousing and logistics solutions

C2 PHARMA continues to be a pivotal player in the pharmaceutical industry, dedicated to sustainable practices and the development of innovative solutions. Readers can find more information at c2pharma.com.